about
Crystal structures of murine carnitine acetyltransferase in ternary complexes with its substratesAntidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetesIsothermal titration calorimetry with micelles: Thermodynamics of inhibitor binding to carnitine palmitoyltransferase 2 membrane proteinBeneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineDynamics of the cellular metabolome during human cytomegalovirus infectionCrystal structure of rat carnitine palmitoyltransferase II (CPT-II)Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.Endogenous red blood cell membrane fatty acids and sudden cardiac arrest.Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches.Malonyl-CoA: the regulator of fatty acid synthesis and oxidation.Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice.Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adultsOmega-9 Oleic Acid Induces Fatty Acid Oxidation and Decreases Organ Dysfunction and Mortality in Experimental Sepsis.Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet.Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates.CoA protects against the deleterious effects of caloric overload in DrosophilaTargeted Metabolomics of Serum Acylcarnitines Evaluates Hepatoprotective Effect of Wuzhi Tablet (Schisandra sphenanthera Extract) against Acute Acetaminophen Toxicity.Oleoyl-L-carnitine inhibits glycine transport by GlyT2Effect of L-carnitine Supplementation on Circulating C-reactive Protein Levels: A Systematic Review and Meta-Analysis.Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children.Effect of dietary calcium and dairy proteins on the adipose tissue gene expression profile in diet-induced obesityAnalysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in miceThe mechanistic basis for the induction of hepatic steatosis by xenobiotics.Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth.Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.Pro-inflammatory and oxidative stress pathways which compromise sperm motility and survival may be altered by L-carnitine.Carnitine deficiency and its possible risk factors in TB patients: first report.Fat and cardiotoxicity in hereditary pulmonary hypertension.The coactivator SRC-1 is an essential coordinator of hepatic glucose production.A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats.Comparison of the catalytic activities of three isozymes of carnitine palmitoyltransferase 1 expressed in COS7 cells.Glucose concentration and streptomycin alter in vitro muscle function and metabolism.Contractile and metabolic properties of engineered skeletal muscle derived from slow and fast phenotype mouse muscle.Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
P2860
Q24607519-36A9A321-7960-4F02-99CC-D49C9AC32980Q24629052-1986DE9B-F454-4AB2-B41B-23BF43BB37E7Q27678642-5D42F73D-15E3-4BE8-B6D5-3206E474989FQ28081950-1B6ACA9B-D538-4469-8361-746FCDFDCFE6Q28395286-FD9983AF-F838-42E4-BF1A-F3817DD7BAA9Q28469080-BFC30C94-07D2-4661-AF92-F84ECA1E898DQ28578888-54230CAF-10E9-4933-8F70-9EAC1431222EQ33247790-EE942EF6-5DDB-484E-BE2D-43A0929C37D3Q33900900-68902C8C-57D5-4A91-9749-01E3D34FE5ACQ34307355-CCF1D356-BDE5-4B3A-AA47-0BF829555C79Q34318248-850C8F5D-0849-4496-AFA2-C70DFB792212Q34352236-449DBFDC-204D-43B0-BD6D-1B505EAA8531Q34473894-CD34F4D7-CC1E-49A0-A6A3-29B949C4F173Q34991930-0FF98746-6A35-47AF-BFBA-9DA2E91AA4FDQ35025480-27962497-6854-460C-B62E-7477E9040D82Q35990090-AB428277-32E2-456F-AADB-CBB2CBF19A35Q36212235-1B68C45F-22AE-4C85-BD08-87F5FF47887EQ36418591-0FDD3765-0F42-4EF5-B2EF-D3B4AF7534A4Q36617438-B70C7470-2BBC-46DE-8343-D1B25ABB9E2BQ36619354-9BF4A13F-56C5-4221-90CE-ACA898120CB2Q36781047-4A4B5F58-6A25-4BBD-8043-23629F41F698Q37041227-BED7EAF5-A37F-4A86-87A4-E1240A8B21FBQ37163177-8159BD09-E222-46D4-AED6-4D2743A9240BQ37304133-F134F206-66EE-44C8-B830-2B8B92AD3075Q37466801-784EA0A6-8C89-4D6B-9BCC-DE96D9B8C880Q37706542-A26B5471-CDF1-4C49-971F-AAA59A176D84Q37867697-47C093D6-52A4-490C-AA46-2DD6B2CDD015Q38019608-7A9AE720-4D99-4FDA-A039-CC1BD12EA398Q38696841-C6E5221E-9FBF-475A-87B0-8A4F24153AC0Q40222158-BF093240-3532-4C0D-A193-AE7017765429Q40909680-828B1644-9D52-464E-B5A4-B228D0AEA4A2Q42131288-B1C174D3-B8F5-419A-A768-07C84DE17E24Q42249006-5FD5835C-E07C-43DE-9CEE-E44FF6B68BA0Q42372074-1D476097-4E93-48CA-840A-386C145841A4Q42576773-0D2AFE37-81CB-4362-AFA8-586EDD95C518Q42826888-F61AF37E-C62F-4392-BFC1-8DCEA3824D86Q45418153-49C7A8C4-28D5-46B3-BAF4-C64E099AE70EQ46028501-492D80EC-605A-4CDB-869E-A068352EA453Q46526576-D0553E28-16BE-4C60-85C1-156978C2A5D2Q46632067-5F491334-BA50-40B4-8206-CD411ABFB3FC
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of the carnitine system in human metabolism.
@ast
The role of the carnitine system in human metabolism.
@en
type
label
The role of the carnitine system in human metabolism.
@ast
The role of the carnitine system in human metabolism.
@en
prefLabel
The role of the carnitine system in human metabolism.
@ast
The role of the carnitine system in human metabolism.
@en
P356
P1476
The role of the carnitine system in human metabolism.
@en
P2093
Daniel W Foster
P356
10.1196/ANNALS.1320.001
P407
P577
2004-11-01T00:00:00Z